RecallDepth
Class II Ongoing

Valsartan Tablets, USP 160 mg, 90-count bottle (NDC 0591-2169-19), 1000-count bottle (NDC 0591-2169-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054

Company
Teva Pharmaceuticals Usa
Recall Initiated
July 16, 2018
Posted
August 1, 2018
Recall Number
D-0988-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
15,347 90-count bottles, 8,378 1000-count bottles
Firm Location
North Wales, PA, United States

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution

Product was distributed throughout the United States, including Hawaii and Puerto Rico

Lot / Code Info

NDC 0591-2169-19 Lot Numbers: 1177880A, 1220831A, 1263941A NDC 0591-2169-10 1175922M, 1220826M, 1236294M, 1240427M, 1270616A

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls